Back to Search
Start Over
Supplementary table 2 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- All adverse events experienced by patients, including those unrelated to treatment
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....33391d10356f03b97e38938e2760c5b5
- Full Text :
- https://doi.org/10.1158/1078-0432.22488812.v1